Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-067044
Date:2021-11-25
Issuer: VIRACTA THERAPEUTICS, INC. (VIRX)
Original Submission Date:

Reporting Person:

ROYSTON IVOR
C/O VIRACTA THERAPEUTICS, INC.
2533 S COAST HWY 101, SUITE 210 CARDIFF, CA 92007

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-11-25 M 50,437 a $0.00 599,036 direct
COMMON STOCK 2021-11-26 S 11,914 d $4.80 587,122 direct
COMMON STOCK 2021-11-29 S 15,833 d $4.82 571,289 direct
COMMON STOCK 2021-11-25 0 $0.00 18,599 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2021-11-25 deemed execution date M 50,437 (d) common stock 50,437 $0.00 353,066 direct
Footnotes
IDfootnote
f1 each restricted stock unit ("rsu") represents a contingent right to receive one share of viracta therapeutics, inc. common stock.
f2 the sale reported on this form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of rsus. the sale is mandated by the reporting person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction.
f3 represents the weighted average share price of an aggregate total of 11,914 shares sold in the price range of $4.7150 to $5.01 by the reporting person. the reporting person undertakes to provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
f4 represents the weighted average share price of an aggregate total of 15,833 shares sold in the price range of $4.62 to $5.34 by the reporting person. the reporting person undertakes to provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
f5 one-eighth (1/8th ) of the rsu award will vest on november 25, 2021 (the "first vesting date"), and one-sixteenth (1/16th ) of the rsu award will vest each quarterly vesting date (as defined below) after the first vesting date, in each case subject to the reporting person continuing to be a service provider (as defined in the viracta subsidiary, inc. 2016 equity incentive plan, the "plan") through the applicable vesting date. for the purposes of the foregoing, "quarterly vesting date" means february 25, may 25, august 25,and november 25 of each year.

Elevate your investments